The programmed death 1 (PD-1) receptor expressed by activated T-cells is another key immune checkpoint receptor with a negative regulatory role when engaged by its ligands, PDL1 (also known as B7-H1) and PD-L2 (also known as B7-DC), within the tumor microenvironment [45]. This evidence concerns the gene CD274 and neoplasm.